Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPVG.L Regulatory News (PVG)

  • There is currently no data for PVG

Block Listing Application

8 Mar 2016 09:00

RNS Number : 2351R
Premier Veterinary Group PLC
08 March 2016
 

 

 

 

BLOCK LISTING APPLICATION

 

 

London, 8 March 2016: Premier Veterinary Group plc (LSE: PVG) (the "Company") announces that it has made a block listing application to the London Stock Exchange for the admission of up to 1,674,212 ordinary shares of 10 pence each to the Official List of the UK Listing Authority and to trading on the London Stock Exchange's market for listed securities.

 

The block listing application relates to the following:

 

Warrants

 

As part of the arrangements relating to the reverse acquisition by the Company of Premier Veterinary Group Limited (now PVG 2007 Limited) completed in February 2015, warrants were granted over 279,034 ordinary shares of 10 pence each, vesting and becoming exercisable in two equal tranches on 27 February 2016 and 27 February 2017 respectively.

The block listing application is for the total number of shares that could be issued pursuant to the exercise of all of those warrants, representing approximately 2% of the current issued share capital. The application for the admission of these shares has been made in advance for ease of administration.

Further information relating to the warrants can be found in the Company's Annual Report and Accounts 2015 available on its website: www.premiervetgroup.co.uk.

Share options

 

The block listing application also includes a further 1,395,178 shares, being the total number of shares that could be issued pursuant to the exercise of all options currently outstanding under the 2014 Ark Therapeutics Group plc Enterprise Management Incentive Share Option Plan (the "EMI Plan"). If all the options were exercised, the shares that would be issued would represent approximately 10% of the current issued share capital.

The application for the admission of these shares has been made in advance for ease of administration as all the outstanding options under the EMI Plan vested and became exercisable on 27 February 2016.

 

 

Shares issued pursuant to the exercise of the warrants and the options under the EMI Plan will rank pari passu with the existing ordinary shares of 10 pence each in the share capital of the Company.

 

It is expected that the block admission will become effective on 9 March 2016.

 

 

Enquiries:

 

Premier Veterinary Group plc

Sue Steven, Company Secretary +44 (0)117 370 0300

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
LISSSFSUWFMSELD
Date   Source Headline
21st Jul 201010:54 amRNSForm 8.5 (EPT/NON-RI)
20th Jul 201011:35 amRNSForm 8.5 (EPT/NON-RI)
20th Jul 201011:00 amRNSForm 8.5 (EPT/RI)
20th Jul 201010:46 amRNSForm 8.3 - [Ark Therapeutics]
19th Jul 201011:39 amRNSForm 8.5 (EPT/RI)
19th Jul 201011:33 amRNSForm 8.5 (EPT/RI)- Amendment 15/07
19th Jul 201011:26 amRNSForm 8.3 - Ark Therapeutics
16th Jul 201012:07 pmRNSForm 8.5 (EPT/RI)
15th Jul 20101:06 pmRNSForm 8.3 - Ark Therapeutics Group PLC
13th Jul 20107:00 amRNSARK UPDATE AND BOARD CHANGES
9th Jul 201010:16 amRNSForm 8.3 - Ark Therapeutics Group PLC - Amendment
8th Jul 201010:27 amRNSForm 8.3 - Ark Therapeutics Group PLC
7th Jul 20101:54 pmPRNForm 8.3 - Ark Therapeutic Group Plc
7th Jul 201011:50 amRNSForm 8.5 (EPT/NON-RI)
6th Jul 20102:49 pmPRNForm 8.3 - Ark Therapeutics Groups Plc
6th Jul 201011:36 amRNSForm 8.5 (EPT/NON-RI)
2nd Jul 20102:15 pmPRNForm 8.3 - Ark Therapeutic Group Plc
2nd Jul 201011:45 amRNSForm 8.5 (EPT/NON-RI)
1st Jul 201011:36 amRNSForm 8.5 (EPT/RI)
30th Jun 20102:45 pmPRNForm 8.3 - Ark Therapeutic Group
30th Jun 201011:45 amRNSForm 8.5 (EPT/NON-RI)
29th Jun 20103:06 pmPRNForm 8.3 - Ark Therapeutic Group Plc
25th Jun 20102:34 pmPRNForm 8.3 - Ark Therapeutics Group Plc
25th Jun 201010:52 amRNSForm 8.5 (EPT/RI)-Amendment
24th Jun 201011:39 amRNSForm 8.5 (EPT/NON-RI)
24th Jun 201010:23 amRNSForm 8.5 (EPT/RI)
23rd Jun 201011:45 amRNSForm 8.5 (EPT/NON-RI)
23rd Jun 201011:39 amRNSForm 8.5 (EPT/RI)
22nd Jun 20102:50 pmPRNForm 8.3 - Ark Therapeutics
22nd Jun 201011:41 amRNSForm 8.5 (EPT/RI)
21st Jun 20102:48 pmRNSForm 8.3 - Ark Therapeutics Group plc
21st Jun 20102:07 pmPRNForm 8.3 - ARK THERAPEUTIC PLC
21st Jun 20101:16 pmRNSForm 8.3 - Ark Therapeutics Plc
21st Jun 201010:48 amRNSForm 8.5 (EPT/RI)
18th Jun 20102:33 pmPRNForm 8.3 - Ark Therapeutics Group Plc
18th Jun 201012:19 pmRNSForm 8.3 - Ark Therapeutics Plc
18th Jun 201011:45 amRNSForm 8.5 (EPT/NON-RI)
18th Jun 201011:02 amRNSHolding(s) in Company
17th Jun 20102:42 pmPRNForm 8.3 - Ark Therapeutics Group
17th Jun 20102:41 pmRNSForm 8.3 - Ark Therapeutics Group PLC
17th Jun 20101:47 pmRNSForm 8.3 - Ark Therapeutics Plc
17th Jun 201011:32 amRNSForm 8.5 (EPT/NON-RI)
16th Jun 201011:25 amRNSForm 8.5 (EPT/RI)
16th Jun 20109:19 amRNSForm 8.5 (EPT/NON-RI)
15th Jun 20103:12 pmRNSForm 8.3 - Ark Therapeutics Group PLC
15th Jun 20102:43 pmPRNForm 8.3 - Ark Therapeutics Group Plc
15th Jun 201012:38 pmRNSForm 8.3 - Ark Therapeutics Plc
15th Jun 20109:47 amRNSForm 8.5 (EPT/NON-RI)
14th Jun 20103:08 pmRNSForm 8.3 - Ark Therapeutics Group PLC
14th Jun 20101:30 pmRNSForm 8.3 - Ark Therapeutics Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.